Loxo Oncology CS (LOXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LOXO | CRNX | ORKA | ||
| Company | Loxo Oncology CS | Crinetics Pharmaceuticals Inc | Oruka Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 234.80 | 84.38 | 106.02 | ||
| High | 234.80 | 84.70 | 111.37 | ||
| Low | 234.80 | 84.36 | 105.10 | ||
| Last | 234.80 | 84.70 | 111.04 | ||
| Change | +0.14 | +0.26 | +2.92 | ||
| Percent Change | +0.06% | +0.31% | +2.70% | ||
| Volume | 800 | 2,279,000 | 1,047,400 | ||
| 20-Day Average Volume | 642,620 | 2,614,655 | 792,040 | ||
| Previous | 234.66 | 84.44 | 108.12 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 234.28 | 83.97 | 97.47 | ||
| 20-Day Raw Stochastic | 92.26% | 99.19% | 98.74% | ||
| 20-Day Relative Strength | 75.87 | 87.81 | 70.68 | ||
| Weighted Alpha | +47.60 | +50.86 | +543.76 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Yesterday's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 56% Buy | 88% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.16% since 02/08/19 | +0.74% since 08/07/26 | +12.37% since 08/07/26 | ||
| Low | 234.43 on 02/11/19 | 83.96 on 08/10/26 | 95.50 on 08/10/26 | ||
| High | 234.93 on 02/13/19 | 84.71 on 08/13/26 | 111.37 on 08/14/26 | ||
| 1-Month | |||||
| %Chg | +0.48% since 01/15/19 | +1.18% since 07/14/26 | +26.95% since 07/14/26 | ||
| Low | 233.14 on 01/16/19 | 83.47 on 07/31/26 | 80.72 on 07/17/26 | ||
| High | 234.93 on 02/13/19 | 84.71 on 08/13/26 | 111.37 on 08/14/26 | ||
| 3-Month | |||||
| %Chg | +54.95% since 11/15/18 | +121.09% since 05/14/26 | +73.77% since 05/14/26 | ||
| Low | 125.00 on 12/24/18 | 32.30 on 06/02/26 | 53.62 on 06/01/26 | ||
| High | 234.93 on 02/13/19 | 84.71 on 08/13/26 | 111.37 on 08/14/26 | ||
| 6-Month | |||||
| %Chg | +49.33% since 08/15/18 | +98.36% since 02/13/26 | +244.74% since 02/13/26 | ||
| Low | 125.00 on 12/24/18 | 32.30 on 06/02/26 | 31.08 on 02/19/26 | ||
| High | 234.93 on 02/13/19 | 84.71 on 08/13/26 | 111.37 on 08/14/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,182,943 | 8,956,129 | 7,158,625 | ||
| Shares Outstanding, K | 30,615 | 106,065 | 66,210 | ||
| Annual Sales, $M | 21,300,000 | 7,700,000 | 0 | ||
| Annual Net Income, $M | -148,880,000 | -465,320,000 | -105,430,000 | ||
| Last Qtr Sales, $M | 42,470,000 | 25,120,000 | 0 | ||
| Last Qtr Income, $M | -27,060,000 | -120,860,000 | -31,820,000 | ||
| 60-Month Beta | 2.51 | 0.12 | -0.34 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.89 on 11/08/18 | -1.14 on 08/03/26 | -0.55 on 08/10/26 | ||
| Latest Earnings Date | 03/07/19 | 11/05/26 | 11/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||